Bringing Patient-Centricity to Clinical Trials

Clinical trials for rare disease therapies can pose some unusual logistical challenges that can make it difficult to get patients to participate or remain enrolled in the trial until its completion. Clincierge provides a service that aim to reduce barriers to trial participation. It arranges travel and housing logistics, provides payment and reimbursement systems to address out-of-pocket expenses for patients, and supports family and caregivers to address a patient’s special needs. We spoke to Scott Gray, CEO of Clinicierge, about the challenges drug developers face in rare disease trials, what Clinicierge does to address them, and how its service reflects the growing trend toward patient-centricity.